Professional
Added to YB: 2024-08-13
Pitch date: 2024-07-01
DVYSR.ST [bullish]
Devyser Diagnostics AB (publ)
-46.49%
current return
Author Info
No bio for this author
Company Info
Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
Market Cap
SEK 1.1B
Pitch Price
SEK 112.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.35
P/E
70.41
EV/Sales
4.01
Sector
Biotechnology
Category
growth
Protean Funds Scandinavia AB Portfolio Holding: Devyser Diagnostics AB
DVYSR.ST: Devyser Diagnostics AB momentum builds with largest order yet. Thermo Fisher global rights deal for post-transplant products. Organic sales growth acceleration expected H2, driving profitability. Recent order streak signals positive outlook.
Read full article (1 min)